Castle Rock Hormone Health announced a strategic partnership with Franchise Sidekick to support a national franchise expansion initiative as the company scales its proactive and optimization-focused healthcare model across the United States.
The company says the initiative is intended to support the development of 100 to 250 new clinics in 2026. CRHH states that it currently operates across multiple states in the East Coast, Midwest, and Rocky Mountain region, and is building toward a long-term goal of 1,500 clinics over the next five years.
As interest in preventative care and optimization medicine continues to grow, CRHH says its franchise model is built around standardized clinical and operational systems designed for replication across multiple locations. The company states that its clinics provide hormone therapy, medically guided weight management, and longevity services, including peptides and IV offerings, through a cash-pay structure intended to reduce administrative complexity associated with traditional insurance billing.
According to CRHH, its clinical protocols were developed under the guidance of Dr. Lee Moorer, Castle Rock Hormone Health co-founder and CMO, with an emphasis on consistency, monitoring, and ethical standards. The company’s recurring care model includes ongoing laboratory review and continuous patient monitoring designed to support long-term optimization of metabolic, cognitive, and physical performance. Although traditionally associated with low testosterone and menopausal care, Castle Rock Hormone Health is increasingly serving a broader demographic of patients focused on longevity, prevention, and sustained peak performance.
“Responsible healthcare expansion requires strong infrastructure, clinical governance, and disciplined execution,” said Christopher Stolzman, CEO of Castle Rock Hormone Health. “Our collaboration with Franchise Sidekick supports sustainable national growth.”
CRHH says the partnership is intended to strengthen franchise development and operational support as the company expands into additional markets. “Operational consistency and franchisee support are critical when scaling healthcare concepts,” said Tyler Altenhofen, Chief Growth Officer and co-founder of Franchise Sidekick. “CRHH demonstrates strong alignment across clinical standards and operational systems.”
Castle Rock Hormone Health says it has served more than 10,000 patients nationwide to date and views the partnership as a step toward broader access to proactive and optimization-focused healthcare services across the United States.
About Castle Rock Hormone Health
Castle Rock Hormone Health is a longevity, hormone optimization and replacement franchise serving men and women across multiple U.S. regions, including the East Coast, Midwest, and Rocky Mountain markets. The company provides hormone therapy, medically guided weight loss, peptide and IV therapies, and related services aimed at addressing hormone imbalance and associated symptoms for a growing national patient base exceeding 10,000 individuals to date. For more information, visit crhormonehealth.com.
Disclaimer
This press release is for informational purposes only and does not constitute medical advice, an offer to sell, or a solicitation of an offer to buy any franchise or healthcare service. Any forward-looking statements, including projected clinic growth and expansion plans, are based on current expectations and are subject to risks, uncertainties, and other factors that may cause actual results to differ materially. Healthcare services referenced are subject to applicable laws, regulations, and clinical guidelines, which may vary by jurisdiction. Individuals should consult qualified healthcare professionals before making medical decisions.
Media Contact
Carlos Conde
carlos@crhormonehealth.com
